Cara Therapeutics (NASDAQ:CARA) Earns Sell Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Cara Therapeutics (NASDAQ:CARA – Free Report) in a research report sent to investors on Friday. The firm issued a sell rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently commented on CARA. Needham & Company LLC cut Cara Therapeutics from a buy rating […]
More Stories
Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE:PAC) Receives $195.00 Consensus Target Price from Analysts
Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE:PAC – Get Free Report) has received an average rating of “Moderate Buy”...
Brokerages Set Viking Holdings Ltd (NYSE:VIK) PT at $37.17
Shares of Viking Holdings Ltd (NYSE:VIK – Get Free Report) have received an average rating of “Moderate Buy” from the...
Northern Oil and Gas, Inc. (NYSE:NOG) CFO Sells $18,565.00 in Stock
Northern Oil and Gas, Inc. (NYSE:NOG – Get Free Report) CFO Chad W. Allen sold 500 shares of the company’s...
Fulton Financial Co. (NASDAQ:FULT) Given Consensus Rating of “Hold” by Analysts
Shares of Fulton Financial Co. (NASDAQ:FULT – Get Free Report) have earned an average rating of “Hold” from the five...
R1 RCM Inc. (NASDAQ:RCM) Receives Consensus Recommendation of “Hold” from Brokerages
R1 RCM Inc. (NASDAQ:RCM – Get Free Report) has been assigned an average recommendation of “Hold” from the eighteen ratings...
Teradyne, Inc. (NASDAQ:TER) Receives Average Rating of “Hold” from Brokerages
Shares of Teradyne, Inc. (NASDAQ:TER – Get Free Report) have been assigned an average recommendation of “Hold” from the fifteen...